Comparing the analgesic effect of heat patch containing iron chip and ibuprofen for primary dysmenorrhea: a randomized controlled trial.
BACKGROUND
Primary dysmenorrhea is a common and sometimes disabling condition. In recent years, some studies aimed to improve the treatment of dysmenorrhea, and therefore, introduced several therapeutic measures. This study was designed to compare the analgesic effect of iron chip containing heat wrap with ibuprofen for the treatment of primary dysmenorrhea.


METHODS
In this randomized (IRCT201107187038N2) controlled trial, 147 students (18-30 years old) with the diagnosis of primary dysmenorrhea were enrolled considering the CONSORT guideline. Screening for primary dysmenorrhea was done by a two-question screening tool. The participants were randomly assigned into one of the intervention groups (heat Patch and ibuprofen). Data regarding the severity and emotional impact of the pain were recorded by a shortened version of McGill Pain Questionnaire (SF-MPQ). Student's t test was used for statistical analysis.


RESULTS
The maximum and minimum pain severities were observed at 2 and 24 hours in both groups. The severity of sensual pain at 8, 12, and 24 hours was non-significantly less in the heat Patch group. There was also no significant difference between the groups regarding the emotional impact of pain at the first 2, 4, 8, 12 and 12 hours of menstruation.


CONCLUSIONS
Heat patch containing Iron chip has comparable analgesic effects to ibuprofen and can possibly be used for primary dysmenorrhea.


BACKGROUND
IRCT201107187038N2.
Pregnancy Health Center, Zahedan University of Medical Sciences, Zahedan, Iran. fkermansaravi@yahoo.com.
Shahindokht
S
Navvabi Rigi
Fatihe
F
Kermansaravi
Ali
A
Navidian
Leila
L
Safabakhsh
Ameneh
A
Safarzadeh
Somaye
S
Khazaian
Shahla
S
Shafie
Tahmineh
T
Salehian
D000293:Adolescent; D000328:Adult; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use*; D004412:Dysmenorrhea / Q000188:drug therapy / Q000523:psychology / Q000628:therapy*; D004644:Emotions; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced / Q000379:methods*; D007052:Ibuprofen / Q000627:therapeutic use*; D007501:Iron; D010147:Pain Measurement; D011795:Surveys and Questionnaires; D016896:Treatment Outcome; D055815:Young Adult
D018712:Analgesics, Non-Narcotic; D007501:Iron; D007052:Ibuprofen